Tag: pharmaceutical lifecycle
Pediatric Exclusivity: How FDA Extends Patent Protection Under Section 505A
Explains how pediatric exclusivity extends market protection by blocking FDA generic approvals rather than changing patent dates, covering Section 505A rules and strategic impacts.
